ANI PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Lalwani Nikhil | PRESIDENT & CEO | Award / Grant | 95,530 | — | — | 346,370 | Feb 28, 2023 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Award / Grant | 11,578 | — | — | 47,407 | Feb 28, 2023 |
| Mutz Christopher | HEAD OF RARE DISEASE | Award / Grant | 17,369 | — | — | 55,029 | Feb 28, 2023 |
| Marken James G. | SVP OPS & PROD DEV | Award / Grant | 8,684 | — | — | 133,916 | Feb 28, 2023 |
| Gutwerg Ori | SVP, GENERICS | Award / Grant | 11,578 | — | — | 62,974 | Feb 28, 2023 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | Award / Grant | 11,578 | — | — | 28,947 | Feb 28, 2023 |
| Davis Krista | SVP, CHIEF HR OFFICER | Award / Grant | 8,104 | — | — | 36,695 | Feb 28, 2023 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Award / Grant | 8,104 | — | — | 39,542 | Feb 28, 2023 |
| Mutz Christopher | HEAD OF RARE DISEASE | Tax Withholding | 1,292 | $45.04 | $58,192 | 39,562 | Feb 15, 2023 |
| Gutwerg Ori | SVP, GENERICS | Tax Withholding | 1,275 | $45.04 | $57,426 | 36,369 | Feb 15, 2023 |
| Meridian Venture Partners II GP, L.P. | — | Sale | 200,000 | $38.50 | $7,700,000 | 2,019,259 | Dec 1, 2022 |
| Davis Krista | SVP, CHIEF HR OFFICER | Award / Grant | 16,433 | — | — | 16,433 | Sep 12, 2022 |
| Lalwani Nikhil | PRESIDENT & CEO | Tax Withholding | 3,646 | $37.61 | $137,126 | 281,957 | Sep 8, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Sale | 12,894 | $37.04 | $477,594 | 122,814 | Aug 15, 2022 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Award / Grant | 19,280 | — | — | 19,280 | Jul 18, 2022 |
| Gutwerg Ori | SVP, GENERICS | Award / Grant | 6,476 | — | — | 37,644 | Apr 27, 2022 |
| Mutz Christopher | HEAD OF RARE DISEASE | Award / Grant | 6,476 | — | — | 40,854 | Apr 27, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Award / Grant | 6,644 | — | — | 135,708 | Apr 27, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Award / Grant | 11,291 | — | — | 146,633 | Apr 27, 2022 |
| Lalwani Nikhil | PRESIDENT & CEO | Award / Grant | 33,352 | — | — | 285,603 | Apr 27, 2022 |
| HAUGHEY THOMAS | — | Award / Grant | 10,049 | — | — | 40,251 | Apr 27, 2022 |
| NASH DAVID | — | Award / Grant | 10,049 | — | — | 31,696 | Apr 27, 2022 |
| Pera Antonio R | — | Award / Grant | 10,049 | — | — | 29,762 | Apr 27, 2022 |
| Thoma Jeanne | — | Award / Grant | 10,049 | — | — | 29,334 | Apr 27, 2022 |
| Walsh Patrick D | — | Award / Grant | 10,049 | — | — | 63,437 | Apr 27, 2022 |
| Brown Robert E. JR | — | Award / Grant | 10,049 | — | — | 49,021 | Apr 27, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Tax Withholding | 1,878 | $29.91 | $56,171 | 129,064 | Apr 10, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Tax Withholding | 4,534 | $29.91 | $135,612 | 135,342 | Apr 10, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Tax Withholding | 912 | $29.69 | $27,077 | 139,876 | Apr 6, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Tax Withholding | 337 | $29.69 | $10,006 | 130,942 | Apr 6, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Tax Withholding | 524 | $28.17 | $14,761 | 131,279 | Mar 28, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Tax Withholding | 1,420 | $28.17 | $40,001 | 140,788 | Mar 28, 2022 |
| Mutz Christopher | HEAD OF RARE DISEASE | Award / Grant | 19,428 | — | — | 34,378 | Mar 24, 2022 |
| Gutwerg Ori | SVP, GENERICS | Award / Grant | 19,428 | — | — | 31,168 | Mar 24, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Award / Grant | 19,934 | — | — | 131,803 | Mar 24, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Award / Grant | 33,875 | — | — | 142,208 | Mar 24, 2022 |
| Lalwani Nikhil | PRESIDENT & CEO | Award / Grant | 100,055 | — | — | 252,251 | Mar 24, 2022 |
| Marken James G. | SVP OPS & PROD DEV | Tax Withholding | 2,452 | $27.03 | $66,278 | 111,869 | Mar 23, 2022 |
| CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | Tax Withholding | 4,167 | $27.03 | $112,634 | 108,333 | Mar 23, 2022 |
| Lalwani Nikhil | PRESIDENT & CEO | Tax Withholding | 17,454 | $27.03 | $471,782 | 152,196 | Mar 23, 2022 |
| Lalwani Nikhil | PRESIDENT & CEO | Purchase | 7,224 | $27.69 | $200,033 | 169,650 | Mar 21, 2022 |
| Walsh Patrick D | — | Purchase | 5,000 | $27.76 | $138,800 | 53,388 | Mar 21, 2022 |
| TANNENBAUM RENEE P | — | Award / Grant | 13,346 | — | — | 13,346 | Mar 19, 2022 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | Purchase | 5,000 | $27.87 | $139,350 | 393,226 | Mar 18, 2022 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Purchase | 5,000 | $27.65 | $138,250 | 18,460 | Mar 17, 2022 |
| Mutz Christopher | HEAD OF RARE DISEASE | Tax Withholding | 1,184 | $40.25 | $47,656 | 14,950 | Feb 15, 2022 |
| Gutwerg Ori | SVP, GENERICS | Tax Withholding | 1,167 | $40.25 | $46,972 | 11,740 | Feb 15, 2022 |
| Thoma Jeanne | — | Purchase | 1,072 | $46.47 | $49,816 | 17,785 | Dec 20, 2021 |
| Pera Antonio R | — | Purchase | 3,000 | $42.26 | $126,780 | 19,713 | Dec 7, 2021 |
| HAUGHEY THOMAS | — | Purchase | 2,500 | $39.38 | $98,450 | 30,202 | Dec 6, 2021 |